Optimum Pharma Nordic DK ApS: Financial statements 2019
CVR: 39535238
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Optimum Pharma Nordic DK ApS (CVR 39535238) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 1,154,387 and a net result of DKK -128,649. The profit margin was -11.1%. Equity in the 2019 report amounted to DKK -139,821.
- Revenue
- DKK 1,154,387
- Gross Profit
- DKK -83,649
- Profit/Loss
- DKK -128,649
- Equity
- DKK -139,821
- Total Assets
- DKK 2,067
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Optimum Pharma Nordic DK ApS has published its interim report for the period April 30, 2018 to December 31, 2018.
As of February 19, 2019, Brian Andersen has joined the board of directors of Optimum Pharma Nordic DK ApS.
As of February 19, 2019, Finn Ulbæk Andersen has joined the board of directors of Optimum Pharma Nordic DK ApS.
As of February 19, 2019, Finn Ulbæk Andersen is registered as adm. dir. of Optimum Pharma Nordic DK ApS.
As of February 19, 2019, Åke Erland Nygren is registered as chairman of Optimum Pharma Nordic DK ApS.
As of February 19, 2019, Anne Birgitte de Jonquières Gammeljord has stepped down as liquidator of Optimum Pharma Nordic DK ApS.
On February 19, 2019, Optimum Pharma Nordic DK ApS exited liquidation.
About Optimum Pharma Nordic DK ApS
Optimum Pharma Nordic DK ApS was a Danish company of the type Anpartsselskab based in Hvidovre, founded in 2018. The company has been dissolved on 1 June 2023. The company was registered under the industry Anden undervisning i.a.n.. In 2019, the company reported revenue of DKK 1,154,387 and a net result of DKK -128,649. Equity in the 2019 report amounted to DKK -139,821.